SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI
CCSI 29.77+3.7%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter V who wrote (3524)6/25/1998 8:20:00 PM
From: Cacaito  Read Replies (2) of 5736
 
rockefeller.edu

"Even in developed nations such as the United States, SnMP could provide a simple, inexpensive and more
desirable therapy. Of the roughly 4 million births in the United States each year, about 75 percent or two and a
half million infants develop visible jaundice. In about 10 percent of these infants, jaundice becomes severe
enough to warrant treatment with light to prevent potential damage to the central nervous system."

At least, from a source away from the CCSI/Asensio dyad.

The 10% of treated babies is probably lower now with the recent recommendations from the American Academy of Pediatrics on Hyperbilirubinemia in Healthy Newborns, they recommend less treatment (and less testing) in infants in whom hemolytic disease is not suspected and are healthy (which are the majority of the jaundice babies.)

In my opinion, CCSI should have no problem with the billing codes, if they are able to show to insurance companies the correspondent and "substantial" savings when comparing to the heel stick blood sample, which I do not consider difficult for CCSI to do.

statcan.ca

last one for the Canadian babies. Lets calculate the market size.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News